CIK 0001623526 · Non-accelerated filer<br>Smaller reporting company
Stoke Therapeutics, Inc.
Sign in to watch- Ticker
- STOK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471144582
- Phone
- 781-430-8200
- Business address
- 45 WIGGINS AVENUE, BEDFORD, MA, 01730
- Former names
- ASOthera Pharmaceuticals, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,050,832
- in 7 filings, $404K under 10b5-1 plans
Net −$1,050,832. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Restricted Stock Units | −7,475 | 7,475 | ||
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Restricted Stock Units | −6,000 | 12,000 | ||
| 2026-03-15 | Allan Jonathan GENERAL COUNSEL & CORP SEC | Option exercise · Restricted Stock Units | −12,000 | 36,000 | ||
| 2026-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise | +13,100 | 32,898 | ||
| 2026-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise | +10,000 | 42,898 | ||
| 2026-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise | +10,750 | 53,648 | ||
| 2026-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −13,100 | 13,100 | ||
| 2026-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −10,000 | 20,000 | ||
| 2026-03-15 | Ticho Barry CHIEF MEDICAL OFFICER | Option exercise · Restricted Stock Units | −10,750 | 32,250 | ||
| 2026-03-15 | Leggett Thomas Chief Financial Officer | Option exercise | +14,750 | 14,750 | ||
| 2026-03-15 | Leggett Thomas Chief Financial Officer | Option exercise · Restricted Stock Units | −14,750 | 44,250 | ||
| 2026-03-15 | Hoitt Jason Chief Patient Officer | Option exercise | +10,000 | 13,988 | ||
| 2026-03-15 | Hoitt Jason Chief Patient Officer | Option exercise · Restricted Stock Units | −10,000 | 30,000 | ||
| 2026-03-15 | Kaye Edward M. MD Director | Option exercise | +35,500 | 84,624 | ||
| 2026-03-15 | Kaye Edward M. MD Director | Option exercise | +26,250 | 110,874 | ||
| 2026-03-15 | Kaye Edward M. MD Director | Option exercise · Restricted Stock Units | −35,500 | 35,500 | ||
| 2026-03-15 | Kaye Edward M. MD Director | Option exercise · Restricted Stock Units | −26,250 | 52,500 | ||
| 2026-03-13 | LEVIN ARTHUR A Director | Sale 10b5-1 | −605 | $36.80 | $22K | 4,237 |
| 2026-03-10 | Krainer Adrian R. Director | Sale 10b5-1 | −33,243 | $39.74 | $1.3M | 283,302 |
| 2026-03-10 | TZIANABOS ARTHUR Interim Executive Chair | Option exercise 10b5-1 | +3,955 | $8.33 | $33K | 35,694 |
Page 5 of 13 · 256 trades